Fortress Biotech, INC. (FBIOP) SEC Filings — 2024
28 SEC filings for Fortress Biotech, INC. (FBIOP) in 2024.
Filings
- Fortress Biotech Files 8-K — 8-K · Dec 16, 2024
- Fortress Biotech Amends Avenue Therapeutics Filing — SC 13D/A · Nov 15, 2024
- Fortress Biotech Q3 2024: Assets $19.7M, Liabilities $7.2M — 10-Q · Nov 14, 2024
- Fortress Biotech Files 8-K Report — 8-K · Nov 4, 2024
- Fortress Biotech, INC. SC 13G Filing — SC 13G · Oct 25, 2024
- Fortress Biotech Files SC 13D/A for Checkpoint Therapeutics — SC 13D/A · Oct 1, 2024
- Fortress Biotech Files S-1 Registration — S-1 · Sep 27, 2024
- Rosenwald Amends Fortress Biotech Stake Filing — SC 13D/A · Sep 25, 2024
- Fortress Biotech Enters Material Agreement, Reports Equity Sales — 8-K · Sep 23, 2024
- Fortress Biotech Q2 2024: Assets $225.9M, Liabilities $15.1M — 10-Q · Aug 13, 2024
- Fortress Biotech Files 8-K on Agreements and Equity Sales — 8-K · Jul 25, 2024
- Fortress Biotech Enters Material Definitive Agreement — 8-K · Jul 19, 2024
- Fortress Biotech Files 8-K — 8-K · Jul 5, 2024
- Fortress Biotech Amends Mustang Bio Stake Filing — SC 13D/A · Jun 28, 2024
- Fortress Biotech Files 8-K on Equity Sale — 8-K · Jun 28, 2024
- Fortress Biotech Files 8-K for Corporate Changes — 8-K · Jun 25, 2024
- Fortress Biotech Sells Fortress Vision for $15M — 8-K · May 29, 2024
- Fortress Biotech Files SC 13D/A Amendment — SC 13D/A · May 17, 2024
- Fortress Biotech Files 8-K on Financials — 8-K · May 15, 2024
- Fortress Biotech, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Fortress Biotech Amends Filing for Avenue Therapeutics — SC 13D/A · Apr 17, 2024
- Fortress Biotech Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 5, 2024
- Fortress Biotech Files 8-K on Financials — 8-K · Mar 28, 2024
- Fortress Biotech, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Fortress Biotech Amends SEC Filing for Checkpoint Therapeutics — SC 13D/A · Mar 22, 2024
- Fortress Biotech, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Fortress Biotech 8-K: Officer/Director Changes & Comp Arrangements — 8-K · Jan 26, 2024
- Fortress Biotech Enters Material Definitive Agreement — 8-K · Jan 3, 2024